SANOFINSESanofi India Limited· PharmaceuticalsMinimalNeutral
Announced Wed, 9 Apr · 17:30 IST

Sanofi India Limited has informed the Exchange about Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sanofi India has submitted a regulatory certificate to the stock exchange as required under SEBI's Depositories and Participants Regulations, 2018. This is a routine compliance filing where the company confirms details related to shares held in physical form and those that have been converted into dematerialized (electronic) form. The submission is typically done by the company's Registrar and Share Transfer Agent on a quarterly basis. No changes to shareholding structure or business operations are involved in this filing.

Likely market impact

This is a standard regulatory compliance disclosure with no material impact on the company's financials, operations, or stock price. Investors can ignore this as a routine procedural filing.